Skip to main content
OpenTrials
Completed

NCT Number: NCT06140368

Virtual Realityon Pain, Anxiety and Comfort During Trigger Point Injection

To determine the effects of virtual reality application during trigger point injection on patients' pain, anxiety and comfort levels.This research was planned as a randomized controlled experimental type. The population of the research was planned to include patients who applied to the Algology polyclinic for trigger point injection. The sample of the research will consist of 150 patients who meet the sampling criteria and agree to participate in the research.Inclusion criteria: Trigger point injection applied for the first time, 18 years and over, understand and speak Turkish, understand verbal and written information given.Patients will be divided into two groups: experimental (virtual reality) and control groups.Data will be collected with the Case Report Form, State Anxiety Scale, General Comfort Scale and Visual Analog Scale.Patients' anxiety, comfort and pain levels will be evaluated before and after trigger point injection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Virtual Reality Anxiety Disorders Mental Disorders Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Elif Günay İsmailoğlu

Izmir, Menemen, 35160, Turkey (Türkiye)

About this study

Patients in the experimental group will be shown videos that the patient wants to watch, such as nature and seaside walks, underwater videos, with music background, through virtual reality glasses for 10 minutes.Patients in the control group will continue routine practice.Patients' anxiety, comfort and pain levels will be evaluated before and after trigger point injection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The procedure will be applied for the first time
  • 18 years and over
  • Able to understand and speak Turkish
  • Able to understand verbal and written information given
  • Having good cognitive abilities
  • Without visual or hearing loss
  • Patients who agreed to participate in the study

Exclusion criteria

  • Those who do not understand or speak Turkish
  • Does not understand verbal and written information
  • Those with impaired cognitive abilities
  • Epilepsy

Treatment and study plan

Virtual reality

Behavioral

During the trigger point injection, patients will be shown videos that the patient wants to watch, such as nature and seaside walks, underwater videos, with music background, through virtual reality glasses for 10 minutes.

Primary outcomes

  1. State Anxiety Scale

    Time frame: 10 minutes after procedure

    The scale developed by Spielberger et al. aims to measure state and trait anxiety levels separately.The scores obtained from the scale vary between 20-80, and the total score between 20-39 indicates mild anxiety, between 40-59 indicates moderate anxiety, and between 60-79 indicates severe anxiety.

  2. General Comfort Scale

    Time frame: 10 minutes after procedure

    The scale, which was developed by Kolcaba in 2006 and has a total of 28 questions as 'Refreshing (9 items), Relaxation (9 items) and Overcoming Problems (10 items), consists of three sub-dimensions.The lowest value that can be taken is 1, which indicates low comfort, and the highest value, 6, indicates high comfort.

  3. Visual Analog Scale

    Time frame: In the middle (10 minutes) of the procedure

    It is aimed to determine the level of pain.0 means no pain and 10 means maximum pain

Sponsors and collaborators

Lead sponsor

Izmir Bakircay University

Other

Registry information

Official study title

The Effect of Virtual Reality on Pain, Anxiety and Patient Comfort During Trigger Point Injection

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Nov 20, 2023
Registry last updated
Dec 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.